Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Not Sure I Believe the Warrant Theory

From the 13G. I believe the last two sentances make it clear that S&L are deemed one entity for reporting purposes. Hence 9.9% for both. Yes?

"Lincoln Ventures, LLC (“Lincoln”) and Swartz Private Equity, LLC (“SPE”), each hold Warrants to purchase common stock of the company. The documents governing the terms of the Warrants contain a provision prohibiting Lincoln and SPE, as applicable, from exercising warrants for shares of Common Stock if doing so would result in the Reporting Persons and their affiliates beneficially owning shares of Common Stock that represent more than 9.99% of the outstanding shares of Common Stock as determined under Section 13(d) of the Securities Exchange Act of 1934. As a result, the Reporting persons did not beneficially own more than 9.99% of the outstanding Common Stock. This number assumes that Lincoln Ventures, LLC and Swartz Private Equity, LLC may be deemed to be affiliated and under common control." Opty


Feb 28, 2007 03:51AM

Feb 28, 2007 04:14AM

Feb 28, 2007 04:17AM

Feb 28, 2007 09:41AM

Feb 28, 2007 10:38AM

Feb 28, 2007 10:59AM

Feb 28, 2007 11:09AM

Feb 28, 2007 11:10AM

Feb 28, 2007 12:25PM
Share
New Message
Please login to post a reply